Daily Poll: To squeeze or not to squeeze.
The apparent short squeeze that began last week in $Longeveron (LGVN.US)$ is continuing on Wednesdays as the share price has been up 122%.
Among speculative biotech stocks, Longeveron continues to outperform the market by a wide margin. Trading at only $3 per share a week ago, shares of LGVN stock has skyrocketed to more than $40 per share.
Some investors relate the upward trend with the FDA approval of their Lomacel-B drug for a Rare Pediatric Disease. But is that the main reason?
Some investors relate the upward trend with the FDA approval of their Lomacel-B drug for a Rare Pediatric Disease. But is that the main reason?
Some people said this stock is like $Biora Therapeutics (PROG.US)$ 's bigger younger brother.
Do you agree? Are you going to make any move?
Do you agree? Are you going to make any move?
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment
Moomoo Community Official Account
Bringing you insights, inspiration and the hottest content.
152KFollowers
1203Following
63KVisitors
Follow
lusy bubb : I'm optimistic about it in a short time, but I can't judge it in the long run
Bull Run : Down back 50% from peak short play by shorter. Those bought at peak going to burn their hand.